PUBLISHER: Grand View Research | PRODUCT CODE: 1888746
PUBLISHER: Grand View Research | PRODUCT CODE: 1888746
The global urology surgical instruments market size was estimated at USD 12.88 billion in 2024 and is expected to reach USD 25.24 billion by 2033, growing at a CAGR of 7.52% from 2025 to 2033. The urology surgical instruments market is expanding rapidly due to numerous factors, including the rising geriatric population and the increasing prevalence of urological problems such as kidney stones, involuntary leakage of urine (urinary incontinence), benign prostatic hyperplasia (BPH, or enlarged prostate), and cancers affecting the urinary system.
These disorders necessitate surgical intervention, which increases the demand for urological surgical instruments. The growing burden of benign prostatic hyperplasia (BPH) is expected to drive the demand for urology surgical instruments significantly in the coming years. Surgical instruments, such as catheters, play a crucial role in the management of BPH by providing immediate relief from urinary symptoms and significantly enhancing patients' quality of life. In individuals with BPH, urinary catheters offer a direct pathway for urine to exit the body, effectively bypassing the blockage caused by an enlarged prostate. Due to their essential role in symptom management and patient care, the rising prevalence of BPH is anticipated to contribute to an increased demand for surgical instruments.
Furthermore, prostate cancer is one of the most commonly diagnosed cancers in men, leading to a growing number of surgical interventions such as prostatectomies and biopsies. This rising volume of procedures drives increased demand for advanced urological surgical instruments, including minimally invasive and robotic-assisted technologies. According to data published by the Indian Journal of Urology in September 2024, prostate cancer is the second most common cancer among males across the globe, accounting for approximately 14.2% of all new cancer cases in men, with an age-adjusted incidence rate of 29.4 per 100,000 population. In addition, urinary incontinence is a common complication following prostate cancer surgery, often resulting from nerve and muscle damage around the bladder. As a result, treatments such as urethral slings and artificial urinary sphincters are increasingly used to manage post-surgical urinary incontinence.
Moreover, the rapidly aging global population is a major factor driving the growth of the urological surgical instruments market, as age-related conditions like benign prostatic hyperplasia (BPH), urinary incontinence, prostate cancer, and kidney stones become increasingly common in older adults. As the number of seniors increases, the demand for diagnostic assessments and surgical interventions to restore urinary function and enhance quality of life rises. This demographic shift is prompting hospitals and surgical centers to expand their urological services and adopt advanced, surgical instruments that offer faster recovery and reduced complications.
Global Urology Surgical Instruments Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global urology surgical instruments market on the basis of product, application, and region: